She is currently leading a multi-disciplinary team in the China Kadoorie Biobank (CKB) of 0.5 million people, responsible for developing strategies and procedures related to validation of electronically reported clinical events and for conducting disease validation and adjudication in collaboration with clinical specialists in China for CKB. Her main research interests are in the fields of clinical epidemiology of cardiovascular diseases, major depression, and sleeping disorders.